- Global Operation
- Contract Manufacturing
Each tablet contains delayed release Naproxen USP and immediate release Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole
It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Solivo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen containing products.
Solivo® 375mg Tablet: 30s tablets in blister pack.
Solivo® 500mg Tablet: 30s tablets in blister pack.